New‐user and prevalent‐user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices

BACKGROUND: Guidance reports for observational comparative effectiveness and drug safety research recommend implementing a new‐user design whenever possible, since it reduces the risk of selection bias in exposure effect estimation compared to a prevalent‐user design. The uptake of this guidance has...

Descripción completa

Detalles Bibliográficos
Autores principales: Luijken, Kim, Spekreijse, Judith J., van Smeden, Maarten, Gardarsdottir, Helga, Groenwold, Rolf H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252086/
https://www.ncbi.nlm.nih.gov/pubmed/33899305
http://dx.doi.org/10.1002/pds.5258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252086/
https://www.ncbi.nlm.nih.gov/pubmed/33899305
http://dx.doi.org/10.1002/pds.5258

Ejemplares similares